Implants are promising for long-term, sustained, and reversible delivery of ARV drugs that may bypass adherence challenges for end users.
Leah M. Johnson, PhD
Advertisement
Articles by Leah M. Johnson, PhD
Advertisement
Latest Updated Articles
- Implants for Delivery of Antiretroviral Drugs for HIV Pre-Exposure Prophylaxis
Published: June 20th 2018 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Is 4 Weeks of Glecaprevir/Pibrentasvir Sufficient to Treat Early Hepatitis C Infection?
2
Antibiotic Shows Promise in Treating Gram-Positive Pneumonia, Including in High-Risk Patients
3
Vaccines as a Secondary Strategy in the Fight Against Antimicrobial Resistance
4
One Third of Chronic Hepatitis B Patients Are Lost to Follow-Up
5
